A letter to HHS signed by more than one-quarter of House of Representatives members is demanding a refrain from meaningful use Stage 3 finalization.
"We believe that the Stage 3 rule should be paused as it should rely on proven technology — designed outside the limitations of current federal requirements — that can support a shift to outcomes and interoperability rather than measures and objectives," the authors wrote.
The letter states that if enacted on schedule in 2017, Stage 3 will only exacerbate the problematic policies of Stage 2 and incentivize technology that emphasizes arbitrary measurements of provider performance, rather than interoperability and improved health outcomes.
"While healthcare providers are committed to implementing EHRs, many are becoming disenchanted by the seemingly unrealistic expectations dictated by the Meaningful Use program," the authors wrote. "Taking the time to get it right now will surely pay dividends in the future."